Mindfulness Based Cognitive Therapy Modified for Visual Symptoms (MBCT-vision) (MBCT-vision)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04184726|
Recruitment Status : Recruiting
First Posted : December 4, 2019
Last Update Posted : June 16, 2020
This is a research study on Mindfulness-Based Cognitive Therapy for visual symptoms (MBCT-vision), to treat patients with debilitating symptoms of visual snow (VS) and is associated visual symptoms, severe light sensitivity (i.e. photophobia) and migrainous visual aura.
Participants will receive an intervention of an 8-week MBCT course modified for visual symptoms, which will involve 8 weeks of once weekly group sessions and home practice between sessions.
|Condition or disease||Intervention/treatment||Phase|
|Visual Snow Syndrome Trailing Phenomenon Photophobia Visual Aura||Behavioral: Mindfulness Based Cognitive Therapy||Not Applicable|
This is a research study on Mindfulness-Based Cognitive Therapy for visual symptoms (MBCT-vision), to treat patients with debilitating symptoms of visual snow (VS) and its associated visual symptoms, severe light sensitivity (i.e. photophobia) and migrainous visual aura.
VS is a condition of persistent flickering dots, like that of an out-of-focus analog television screen, affecting the whole visual field. There can be associated visual symptoms such as after-images, and trailing of images. No clinical trials for treatment have been done for VS. Instead, treatment data comes from patient case reports.
Photophobia describes discomfort or pain to light stimulation. Causes include eye surface issues, migraine, or of an unknown trigger, and can be persistent despite optimum management of underlying causes.
Patients with migrainous visual aura may have troublesome visual disturbances despite optimum migraine treatment.
Previous studies have shown that dysfunction in brain pathways contribute to the above conditions.
Mindfulness-Based Cognitive Therapy is a treatment that combines evidence-based approaches of Mindfulness-Based Stress Reduction and Cognitive Behavioural Therapy (CBT). MBCT is an established 8-week programme designed to develop skills of mindfulness and CBT strategies in individuals, through weekly small-group sessions and structured daily practice between sessions.
Studies on MBCT and mindfulness-based interventions have shown improvements in psychological resilience; physical health including immune function; and neural changes associated with psychological wellbeing.
The investigators propose that MBCT, modified to incorporate aspects relevant to persistent and distressing visual symptoms (MBCT-vision), can improve these debilitating symptoms by modifying dysfunctional neural pathways and equip patients with skills that promote psychological resilience and improve coping with residual symptoms.
For this study, the investigators will assess the use of MBCT-vision in patients with visual snow or associated visual symptoms, migrainous visual aura or photophobia. This will be the first study of a mindfulness-based intervention in this population.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||36 participants|
|Intervention Model:||Single Group Assignment|
|Intervention Model Description:||MBCT-vision intervention|
|Masking:||None (Open Label)|
|Official Title:||Mindfulness Based Cognitive Therapy Modified for Visual Symptoms: MBCT-vision|
|Actual Study Start Date :||January 9, 2020|
|Estimated Primary Completion Date :||December 31, 2020|
|Estimated Study Completion Date :||December 31, 2020|
8 x once weekly group sessions, and home practice between sessions
Behavioral: Mindfulness Based Cognitive Therapy
mindfulness and cognitive behavioural therapy techniques taught in group sessions meeting once weekly for 8 weeks, and home practice between sessions.
Other Name: MBCT
- change in severity of visual symptoms [ Time Frame: week 9 and 20 ]change in severity of visual symptoms pre- and post-intervention, comparing scores on Likert scale, ranging from 0/10 (no symptoms) to 10/10 (extremely severe symptoms)
- change in World Health Organisation (WHO) wellbeing index scores [ Time Frame: week 9 and 20 ]change in WHO wellbeing index, comparing pre- and post- intervention scores. WHO wellbeing index range from 0-25, with higher scores representing increased wellbeing.
- change in Clinical Outcomes in Routine Evaluation (CORE-10) scores [ Time Frame: week 9 and 20 ]change in CORE-10 scores, comparing pre- and post- intervention. CORE-10 scores range from 0-40 with higher scores indicating more distress.
- change in Five-Facet Mindfulness Questionnaire (FFMQ) scores [ Time Frame: week 9 and 20 ]change in Five-Facet Mindfulness Questionnaire scores, comparing pre- and post- intervention. FFMQ scores range from 39-195 where higher scores represent more mindfulness
- compliance (session attendance and completion of daily practice) [ Time Frame: week 9 ]participant compliance from attendance record for MBCT-vision weekly sessions and self-report compliance with daily home practice
- qualitative assessment of MBCT-vision [ Time Frame: week 9 ]participant feedback on the design of MBCT-vision via structured qualitative interview
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04184726
|Contact: MBCT-vision admin||02071887188||MBCTvision@gstt.nhs.uk|
|Guys & St Thomas' NHS Foundation Trust||Recruiting|
|London, United Kingdom|
|Contact: Sui Wong, MD MBCTvision@gstt.nhs.uk|
|Principal Investigator:||Sui H Wong, MD||Guys & St Thomas'|